Patents by Inventor Manuel Perez

Manuel Perez has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20150284507
    Abstract: A method of making a hyperbranched amphiphilic polyester compound includes drying under vacuum a mixture of 2-(4-hydroxybutyl)-malonic acid and p-toluene sulphonic acid as catalyst. The vacuum is then released with a dry inert gas after drying. The dried mixture is heated under the inert gas at a temperature sufficient for polymerization. The inert gas is evacuated while continuing to heat the mixture. The formed polymer is then dissolved in dimethylformamide and precipitated out by adding methanol. Modifications of the method yield nanoparticles of polyesters having properties suited for coencapsulating fluorescent dyes together with therapeutic drugs, resulting in theranostic nanoparticles, that is, nanoparticles useful in both therapeutic treatments and diagnostic methods.
    Type: Application
    Filed: June 19, 2015
    Publication date: October 8, 2015
    Inventors: J. Manuel Perez, Santimukul Santra
  • Patent number: 9125941
    Abstract: The invention discloses an aqueous method of making polymer coated superparamagnetic nanoparticles. Nanoparticles made by the method are included in the invention.
    Type: Grant
    Filed: June 25, 2014
    Date of Patent: September 8, 2015
    Assignee: University of Central Florida Research Foundation, Inc.
    Inventors: Jesus Manuel Perez, Sudip Nath
  • Patent number: 9119391
    Abstract: Methods, systems and compositions are disclosed wherein normal, non-transformed, healthy biological cells are protected from oxidative stress, radiation therapy and chemotherapy while diseased, transformed cells, such as, cancer cells, are provided no protection by the biocompatible, polymer coated nanoceria composition of the present invention. The polymer-coated nanoceria preparation herein exhibits no toxicity to normal cells and exhibits pH-dependent antioxidant properties at neutral or physiological pH values, between approximately 6.5 to approximately 11.0 and is inactive as an antioxidant at acidic pH values between approximately 2.0 to approximately 6.4. Improved therapeutic agents and cytoprotecting devices are based on the newly discovered, pH dependent properties of polymer-coated nanoceria that provide selective cytoprotection.
    Type: Grant
    Filed: July 8, 2008
    Date of Patent: September 1, 2015
    Assignee: University of Central Florida Research Foundation, Inc.
    Inventors: Jesus Manuel Perez, Atul Asati, Sudip Nath, Charalambos Kaittanis
  • Patent number: 9109249
    Abstract: Disclosed herein are methods and materials for facilitating the detection of nucleic acid analytes of interest. Specifically exemplified herein are methods for detecting mycobacterial microorganisms, namely Mycobacterium avium spp. paratuberculosis. Also disclosed is new hybridizing magnetic relaxation nanosensor (hMRS) particularly adapted to detect a target nucleic acid analyte of interest.
    Type: Grant
    Filed: May 21, 2012
    Date of Patent: August 18, 2015
    Assignee: UNIVERSITY OF CENTRAL FLORIDA RESEARCH FOUNDATION, INC.
    Inventors: Saleh Naser, J. Manuel Perez, Charalambos Kaittanis
  • Patent number: 9095611
    Abstract: A method of making a hyperbranched amphiphilic polyester compound includes drying under vacuum a mixture of 2-(4-hydroxybutyl)-malonic acid and p-toluene sulphonic acid as catalyst. The vacuum is then released with a dry inert gas after drying. The dried mixture is heated under the inert gas at a temperature sufficient for polymerization. The inert gas is evacuated while continuing to heat the mixture. The formed polymer is then dissolved in dimethylformamide and precipitated out by adding methanol. Modifications of the method yield nanoparticles of polyesters having properties suited for coencapsulating fluorescent dyes together with therapeutic drugs, resulting in theranostic nanoparticles, that is, nanoparticles useful in both therapeutic treatments and diagnostic methods.
    Type: Grant
    Filed: September 26, 2012
    Date of Patent: August 4, 2015
    Assignee: The University of Central Florida Research Foundation, Inc.
    Inventors: J Manuel Perez, Santimukal Santra
  • Patent number: 9057094
    Abstract: A method of testing bacterial cells for antimicrobial susceptibility includes preparing a suspension of the bacterial cells in a non-nutrient medium, mixing with the suspension an antimicrobial, a carbohydrate usable by the bacterial cells, metallic nanoparticles, and a lectin, and incubating the mixture while monitoring a parameter of the nanoparticles responsive to use of the carbohydrate by the bacterial cells. More broadly stated, the invention includes a method of testing an agent for its effect on cell metabolism by preparing a suspension of cells in a non-nutrient medium, mixing the suspension with the agent, adding a carbohydrate usable by the cells, metallic nanoparticles, and a lectin with binding specificity for the added carbohydrate, and monitoring a nanoparticle parameter responsive to the cells.
    Type: Grant
    Filed: October 27, 2008
    Date of Patent: June 16, 2015
    Assignees: UNIVERSITY OF CENTRAL FLORIDA RESEARCH FOUNDATION, INC., NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS
    Inventors: J. Manuel Perez, Charalambos Kaittanis, Sudip Nath
  • Publication number: 20150087605
    Abstract: Disclosed are compositions and methods for treating anthrax, inhibiting anthrax toxins and inhibiting anthrax toxin-induced cytotoxicity. Carboxylic acid-containing small molecules can be used in the methods and compositions disclosed herein, for example, sulindac and derivatives thereof may be used. Methods of screening for carboxylic acid-containing small molecules that can be used to treat anthrax are disclosed. Targeting the anthrax toxin reduces the risks of anthrax spores.
    Type: Application
    Filed: September 19, 2014
    Publication date: March 26, 2015
    Inventors: J. Manuel Perez Figueroa, Oscar Santiesteban, Charalambos Kaittanis
  • Publication number: 20150023882
    Abstract: The invention discloses an aqueous method of making polymer coated superparamagnetic nanoparticles. Nanoparticles made by the method are included in the invention.
    Type: Application
    Filed: June 25, 2014
    Publication date: January 22, 2015
    Applicant: University of Central Florida Research Foundation, Inc.
    Inventors: Jesus Manuel Perez, Sudip Nath
  • Patent number: 8883519
    Abstract: Methods, systems, compositions include biocompatible polymer coated nanoceria that function as aqueous redox catalyst with enhanced activity at an acidic to moderately alkaline pH value between 1 and 8. The compositions are used as oxidizing agents for decomposition, decontamination or inactivation of organic contaminants, such as, pesticides and chemical warfare agents. Another use includes nanoceria as targetable nanocatalyst prepared by conjugating various targeting ligands to the nanoparticle coating to form a colorimetric or fluorescent probe in immunoassays and other molecule binding assays that involve the use of a molecule in solution that changes the color of the solution or emits a fluorescent signal, where localization of nanoceria to organs or tissue is assessed by treatment with an oxidation sensitive dye or other detection devices.
    Type: Grant
    Filed: February 12, 2010
    Date of Patent: November 11, 2014
    Assignee: University of Central Florida Research Foundation, Inc.
    Inventors: J. Manuel Perez, Atul Asati, Santimukul Santra, Charalambos Kaittanis, Sudip Nath
  • Publication number: 20140324908
    Abstract: The present disclosure relates to the use of both semantic analysis and statistical text mining to process data records, improving the completeness and accuracy of records so processed. By way of example, a data record may be iteratively processed by text mining using seeds derived from a semantic template and by validating the results based on semantic reasoning based on the semantic template.
    Type: Application
    Filed: April 29, 2013
    Publication date: October 30, 2014
    Applicant: GENERAL ELECTRIC COMPANY
    Inventors: Michael Evans Graham, Andrew Walter Crapo, Abha Moitra, Gerald Bowden Wise, Steven Matt Gustafson, Victor Manuel Perez-Zarate, Luis Babaji Ng Tari
  • Publication number: 20140303022
    Abstract: The present invention provides novel compositions of binding moiety-nanoparticle conjugates, aggregates of these conjugates, and novel methods of using these conjugates, and aggregates. The nanoparticles in these conjugates can be magnetic metal oxides, either monodisperse or polydisperse. Binding moieties can be, e.g., oligonucleotides, polypeptides, or polysaccharides. Oligonucleotide sequences are linked to either non-polymer surface functionalized metal oxides or with functionalized polymers associated with the metal oxides. The novel compositions can be used in assays for detecting target molecules, such as nucleic acids and proteins, in vitro or as magnetic resonance (MR) contrast agents to detect target molecules in living organisms.
    Type: Application
    Filed: April 18, 2014
    Publication date: October 9, 2014
    Applicant: The General Hospital Corporation
    Inventors: Lee Josephson, Ralph Weissleder, J. Manuel Perez
  • Patent number: 8840304
    Abstract: A flexible, lightweight, easily maneuverable positioner for an imaging system. The positioning system in one example has a cart section with a base frame coupled to one or more wheels. There is a mast extending from the cart section and a linkage assembly coupled to a second end of the mast, wherein the mast is configured to swing about a vertical plane. There is a positioning arm coupled to the linkage assembly, wherein the positioning arm is configured to swing about at least one of a horizontal plane and the vertical plane. An imaging bracket is used to couple to the positioning arm and configured to receive an imaging unit. In one example, the positioner is coupled together by fasteners, wherein the positioner can be assembled and dis-assembled via the fasteners without tools.
    Type: Grant
    Filed: December 29, 2010
    Date of Patent: September 23, 2014
    Assignee: General Electric Company
    Inventors: Victor Manuel Perez Zarate, Michael Anthony Rumsey, Andrea Marie Schmitz, Jeffrey Wayne Eberhard, Scott Dana Tilton, Tobias George Harvey
  • Patent number: 8821837
    Abstract: The invention discloses an aqueous method of making polymer coated superparamagnetic nanoparticles. Nanoparticles made by the method are included in the invention.
    Type: Grant
    Filed: April 2, 2013
    Date of Patent: September 2, 2014
    Assignee: University of Central Florida Research Foundation, Inc.
    Inventors: Jesus Manuel Perez, Sudip Nath
  • Patent number: 8817324
    Abstract: The present disclosure provides methods and systems for aggregating print jobs of different lengths and/or customers to decrease the need for rewinding and splicing operations. An exemplary embodiment provides a method that comprises identifying individual label-printing jobs (1-8) that can be aggregated onto a roll of substrate (302), and forming an aggregated label-printing job (300). In the aggregated label-printing job (300) a longest print job (8) is imposed adjacent to a first end of the roll of substrate (302), and one or more shorter print jobs (2, 5, 7) are imposed adjacent to the longest print job (8) in the direction of a second end of the roll of substrate (302).
    Type: Grant
    Filed: June 11, 2010
    Date of Patent: August 26, 2014
    Assignee: Hewlett-Packard Development Company, L.P.
    Inventors: Fabio Giannetti, Benjamin I. Dempster, Kok-Wei Koh, Alysha Naples, Jose Manuel Perez
  • Publication number: 20140220565
    Abstract: Disclosed herein are methods and materials for facilitating the detection of nucleic acid analytes of interest. Specifically exemplified herein are methods for detecting mycobacterial microorganisms, namely Mycobacterium avium spp. paratuberculosis. Also disclosed is new hybridizing magnetic relaxation nanosensor (hMRS) particularly adapted to detect a target nucleic acid analyte of interest.
    Type: Application
    Filed: May 21, 2012
    Publication date: August 7, 2014
    Applicant: UNIVERSITY OF CENTRAL FLORIDA RESEARCH FOUNDATION, INC.
    Inventors: Saleh Naser, J. Manuel Perez, Charalambos Kaittanis
  • Patent number: 8795731
    Abstract: A polymer-coated cerium oxide based device and system is disclosed for detecting reactive oxygen species and monitoring chronic inflammation. The device and system encapsulate free therapeutic nanoparticle elements not present in a living body in a prosthetic or implantable unit. Embodiment one is a two-chamber structure with a reactive oxygen species (ROS) scavenging component on one end and at the opposite end is an imaging agent consisting of at least one of a fluorophore capable of fluorescence emission, a chemiluminescent agent, a magnetic relaxation agent and an X-ray contrast agent. Embodiment two is a single chamber device consisting of a multifunctional nanocomposite with a ROS-scavenging nanoparticle constituent (nanoceria) and a multimodal reporting nanoparticle component (i.e. Dex-IO-DiR).
    Type: Grant
    Filed: October 8, 2010
    Date of Patent: August 5, 2014
    Assignee: University of Central Florida Research Foundation, Inc.
    Inventors: Jesus Manuel Perez, Charalambos Kaittanis, Atul Asati, Santimukul Santra
  • Patent number: 8795733
    Abstract: A polymer-coated cerium oxide based device and system is disclosed for detecting reactive oxygen species and monitoring chronic inflammation. The device and system encapsulate free therapeutic nanoparticle elements not present in a living body in a prosthetic or implantable unit. Embodiment one is a two-chamber structure with a reactive oxygen species (ROS) scavenging component on one end and at the opposite end is an imaging agent consisting of at least one of a fluorophore capable of fluorescence emission, a chemiluminescent agent, a magnetic relaxation agent and an X-ray contrast agent. Embodiment two is a single chamber device consisting of a multifunctional nanocomposite with a ROS-scavenging nanoparticle constituent (nanoceria) and a multimodal reporting nanoparticle component (i.e. Dex-IO-DiR).
    Type: Grant
    Filed: September 4, 2012
    Date of Patent: August 5, 2014
    Assignee: University of Central Florida Research Foundation, Inc.
    Inventors: Jesus Manuel Perez, Charalambos Kaittanis, Atul Asati, Santimukul Santra
  • Patent number: 8772343
    Abstract: The invention relates to sulfonamide derivatives, to their use in medicine, to compositions containing them, to processes for their preparation and to intermediates used in such processes. More particularly the invention relates to a new sulfonamide Nav1.7 inhibitors of formula 10 (I):(I) or a pharmaceutically acceptable salt thereof, wherein Z, R1, R2, R3, R4 and R5 are as defined in the description. Nav1.7 inhibitors are potentially useful in the treatment of a wide range of disorders, particularly pain.
    Type: Grant
    Filed: July 6, 2011
    Date of Patent: July 8, 2014
    Assignee: Pfizer Limited
    Inventors: Andrew Simon Bell, Alan Daniel Brown, Russell Andrew Lewthwaite, Manuel Perez-Pacheco, David James Rawson, Robert Ian Storer, Nigel Alan Swain
  • Patent number: 8685977
    Abstract: The invention relates to sulfonamide derivatives, to their use in medicine, to compositions containing them, to processes for their preparation and to intermediates used in such processes. More particularly the invention relates to a new sulfonamide Nav1.7 inhibitors of formula (I): or a pharmaceutically acceptable salt thereof, wherein Ar1, X, R1, R2, R3, R4 and R5 are as defined in the description. Nav 1.7 inhibitors are potentially useful in the treatment of a wide range of disorders, particularly pain.
    Type: Grant
    Filed: July 11, 2011
    Date of Patent: April 1, 2014
    Assignee: Pfizer Limited
    Inventors: Andrew Simon Bell, Alan Daniel Brown, Russell Andrew Lewthwaite, Ian Roger Marsh, David Simon Millan, Manuel Perez Pacheco, David James Rawson, Nunzio Sciammetta, Robert Ian Storer, Paul Anthony Stupple, Nigel Alan Swain, Marcel John De Groot
  • Patent number: D715291
    Type: Grant
    Filed: January 22, 2013
    Date of Patent: October 14, 2014
    Assignee: Mimio, LLC
    Inventors: Christopher M. Cacioppo, Manuel Perez, Hector Padilla, Timothy Higgins, Louis Frank Genatossio